Repaglinide is a prescription oral antidiabetic medication used to improve blood sugar control in people with type 2 diabetes, working by prompting the pancreas to release insulin. It is typically taken before meals to reduce post-meal glucose spikes. The term combines a drug-class name with a pseudo-chemical stem, usually encountered in medical contexts and pharmacology literature.
Full pronunciation guide
